cheaper glp-1 weight loss drugs to become for some under temporary Medicare program Cheapest GLP-1 Options: Affordable Weight

If you're interested in evidence-based, physician-supervised ipamorelin therapy, FormBlends can connect you with a licensed medical provider

To view or add a comment, sign in More Relevant Posts Metoprolol Class Selective 1-adrenergic blocker (cardioselective beta-blocker) Mechanism of Action Blocks 1 receptors in heart heart rate, cardiac output, BP Reduces myocardial oxygen demand Minimal effect on 2 receptors (less risk of bronchospasm than propranolol) Therapeutic Uses Hypertension Angina pectoris Cardiac arrhythmias (especially atrial fibrillation, supraventricular tachycardia) Myocardial infarction (reduces mortality, reinfarction risk) Chronic heart failure (stable patients) Migraine prophylaxis (off-label) Dosage Forms Tablets (Immediate-release, Extended-release) IV injection Adverse Effects Bradycardia, hypotension Fatigue, dizziness, depression Worsening of heart failure (in acute/unstable cases) Cold extremities May mask hypoglycemia symptoms in diabetics Contraindications Severe bradycardia, AV block, sick sinus syndrome Cardiogenic shock Acute decompensated heart failure Caution in asthma/COPD (at higher doses loses selectivity) Key Points 1-selective safer than propranolol in asthma/COPD, but still use cautiously Taper off gradually avoid rebound hypertension/angina Preferred in heart failure and post-MI management #pharmacy #medical #medicine #bpharma To view or add a comment, sign in Heart Failure: Dosing, Titration & Coding Right Heart Failure (HFrEF) management isnt just about being on treatment its about being on the right dose, at the right frequency, with the right documentation

Based on indication, the incretin-based drugs market is segmented into type 2 diabetes mellitus, obesity and weight management, and other metabolic disorders

These challenges underscore the urgent need for innovative and effective drugs to overcome these shortcomings and provide more effective and tolerable treatments for UC patients

PMID: 35949559